Scientific Advisory Board
Integrated Drug Discovery
Disease Based Models
World Pharma News
Trevi Therapeutics Announces Positive Results from Phase 2 Trial in Prurigo Nodularis
NEW HAVEN, CT, USA I October 13, 2016 I Trevi Therapeutics, Inc. (“Trevi” or the “Company”), a late-stage ...
ChemDiv is presenting at the SCI’s event: Innovation in Design, Supply and Acquisition for Compound Screening Libraries, on 14th September 2016 in Hatfield, UK
Dr. Volodymyr Kysil will present on "ChemDiv’s Special and Focused Libraries". Libraries of sp3-enriched fragments, β-turn and α-helix-mimetics, ...
ChemDiv and Insilico Medicine Form A Strategic Alliance to Develop Oncology Focused Libraries Using Artificial Intelligence
ChemDiv, Inc. and Insilico Medicine, Inc. announced the signing of a collaboration agreement aimed at partnering to develop and market ...
A Subsidiary of Rostec Corporation and HTC ChemRar Launch a Joint Venture for Development and Manufacturing of the Next Generation of Antivirals in Russia and the Eurasian Economic Union
SAN DIEGO, CA, June 22, 2016 - National Immunobiological Company (Rostec State Corporation) and ChemRar Pharma (ChemRar HTC) announced the ...